## First-Line Treatment of Streptococcus pyogenes Pharyngitis **Key Point:** Penicillin V (oral) or Penicillin G (parenteral) is the gold-standard first-line agent for all S. pyogenes infections in non-allergic patients. ### Mechanism & Rationale S. pyogenes remains universally susceptible to β-lactam antibiotics. Penicillin achieves excellent tissue penetration into the pharynx and tonsils, with bactericidal activity against the organism. Oral penicillin V is preferred for uncomplicated pharyngitis in an ambulatory, compliant patient. ### Dosing - **Penicillin V:** 250 mg orally 2–3 times daily for 10 days (standard regimen) - **Penicillin G (if parenteral needed):** 1.2 million units IM as single dose (for poor compliance) ### Why Penicillin Over Alternatives | Feature | Penicillin V | Cephalosporin | Macrolide | Clindamycin | |---------|--------------|---------------|-----------|-------------| | **S. pyogenes susceptibility** | 100% | 100% | ~5–10% resistance | ~5–10% resistance | | **Cost** | Lowest | Moderate | Moderate | Moderate | | **Adverse effects** | Minimal | Rare cross-reactivity | GI upset, QT prolongation | C. difficile risk | | **First-line status** | **Yes** | No (reserved for penicillin allergy) | No (2nd-line) | No (2nd-line) | **High-Yield:** S. pyogenes has NOT developed resistance to penicillin in >70 years of use — this is a unique feature that makes penicillin the perpetual first-line agent. **Clinical Pearl:** Even in the era of macrolide resistance, penicillin remains the standard because resistance rates to β-lactams remain zero. There is no clinical indication to use a broader or more expensive agent for non-allergic patients. **Warning:** Do NOT confuse S. pyogenes susceptibility with S. pneumoniae (which has penicillin-resistant strains). S. pyogenes is uniformly penicillin-susceptible.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.